J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll
Why it matters
Johnson & Johnson's stock fell despite beating quarterly expectations due to market concerns about its market share in the PFA sector, where Boston Scientific and Medtronic are gaining ground.
Article tone
Expected market reaction
Market impact analysis based on bearish sentiment with 80% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 35302
Original source
Johnson & Johnson stock fell Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on January 21, 2026. Analysis and insights provided by AnalystMarkets AI.